ISL2
Insulin gene enhancer protein ISL-2
Also known as: FLJ10160, ISL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A47
- Gene
- ISL2
- Ensembl
- ENSG00000159556
- Chromosome
- 15
- Canonical length
- 359 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Rods & Rings
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in axonogenesis; neuron fate specification; and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within negative regulation of neuron differentiation and neuron differentiation. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>Q96A47|ISL2
1 MVDIIFHYPF LGAMGDHSKK KPGTAMCVGC GSQIHDQFIL RVSPDLEWHA ACLKCAECSQ
61 YLDETCTCFV RDGKTYCKRD YVRLFGIKCA KCQVGFSSSD LVMRARDSVY HIECFRCSVC
121 SRQLLPGDEF SLREHELLCR ADHGLLLERA AAGSPRSPGP LPGARGLHLP DAGSGRQPAL
181 RPHVHKQTEK TTRVRTVLNE KQLHTLRTCY AANPRPDALM KEQLVEMTGL SPRVIRVWFQ
241 NKRCKDKKKS ILMKQLQQQQ HSDKTSLQGL TGTPLVAGSP IRHENAVQGS AVEVQTYQPP
301 WKALSEFALQ SDLDQPAFQQ LVSFSESGSL GNSSGSDVTS LSSQLPDTPN SMVPSPVETLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ISL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 3.4 nTPM
Expression across tissuesHPA
Tissue
- vagina: 3.4 nTPM
- pituitary gland: 2.6 nTPM
- cervix: 2.5 nTPM
- prostate: 2.3 nTPM
- colon: 1.9 nTPM
- salivary gland: 1.7 nTPM
Single-cell type
- cone photoreceptor cells: 17 nCPM
- pituitary stem cells: 15 nCPM
- prostatic club cells: 7.5 nCPM
- basal keratinocytes: 6.2 nCPM
- prostatic hillock cells: 6 nCPM
- plasma cells: 4.7 nCPM
Immune cell
- neutrophil: 9.5 nTPM
- non-classical monocyte: 3.5 nTPM
- naive B-cell: 1.8 nTPM
- intermediate monocyte: 0.9 nTPM
- classical monocyte: 0.8 nTPM
- memory B-cell: 0.8 nTPM
Brain region
- medulla oblongata: 1.8 nTPM
- white matter: 1.6 nTPM
- midbrain: 0.6 nTPM
- pons: 0.6 nTPM
- hypothalamus: 0.4 nTPM
- basal ganglia: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axonogenesis
- negative regulation of neuron differentiation
- neuron development
- neuron fate specification
- peripheral nervous system neuron development
- positive regulation of transcription by RNA polymerase II
- retinal ganglion cell axon guidance
- spinal cord motor neuron cell fate specification
- visceral motor neuron differentiation
Molecular functions
- cis-regulatory region sequence-specific DNA binding
- DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- metal ion binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ISL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ISL2 as an antibody target. Whether an autoantibody or antibody against ISL2 could matter depends on whether native ISL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ISL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ISL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...